Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
about
Balancing high accrual and ethical recruitment in paediatric oncology: a qualitative study of the 'look and feel' of clinical trial discussions.Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology groupDown's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.Philadelphia positive acute lymphoblastic leukaemia of childhood.Mechanisms of defective erythropoiesis and anemia in pediatric acute lymphoblastic leukemia (ALL).Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention.Geographic/ethnic variability of chromosomal and molecular abnormalities in leukemia.Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia.Mechanism of ETV6-RUNX1 Leukemia.Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.Analysis of ZAP70 expression in adult acute lymphoblastic leukaemia by real time quantitative PCR.Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in Saudi Arabia: a multi-institutional retrospective national collaborative study.Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation.Genomics in multiple myeloma: biology and clinical implications.Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial.Childhood acute lymphoblastic leukemia.Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.Survival of childhood acute lymphoid leukaemia in Yorkshire by clinical trial era, 1990-2011.A unique complex translocation involving six different chromosomes in a case of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and adverse prognosis.Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization.Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma.Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial.Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries.Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.Acute lymphoblastic leukemiaAcute Lymphoblastic LeukemiaDerivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemiaThree distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaLISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia
P2860
Q30497244-589447A2-444B-492D-B499-35BDCE2E548EQ33647130-A9115F4C-594C-400D-A074-87AD65B4B515Q34798033-282E7FB3-2B3B-4511-99D3-CD6DE6282E9CQ34992080-5EFFFA41-057A-433D-8153-84CDEEE5A320Q35271236-754CEE3A-FDD7-45BC-9AB5-39BFD9A47F41Q35791247-B2F83BD6-29EE-47DD-B9C6-07260680A774Q35849716-61233C97-28E6-492D-9B5A-0F60CD04C55DQ35925012-D86DE5C3-0F17-41D6-9B92-0CB51629E3EDQ36153422-3D740E96-D3D4-44C5-80D5-A9420F35E18EQ36228062-8EEE8F53-6FE9-4732-BFEE-E644BA5B1A2AQ38006380-B5724E19-ADFC-4BED-9CB2-88B248D4E450Q38264774-9FC106D5-D0A0-4DB6-BCB4-0BE6582D005FQ38554534-F37E83E6-BB4B-4CDD-8B45-60A94493ABCBQ38622907-57310B2A-B0E7-4AED-9812-159BF54E3B8EQ38744459-486AE130-F75B-4EEF-B158-C60AF0B5D544Q38813392-82B6D31D-B016-425C-958F-710E2FC35A5CQ39355631-52698673-C719-47EC-A08A-D56BA112E15BQ39367965-1B4423E9-3DFE-4944-8E26-A52A05381519Q39414950-146B8B38-566D-4BE9-AC76-ADDAB059C771Q40391459-A8F25A13-6EEB-4BEA-B033-EF340B40DE30Q40433924-27903339-D39B-4072-A6A1-7338153F5C72Q40637650-6739B940-F116-4C58-8C32-FF77EE49E11BQ40637657-B6929A9E-BA96-4928-B870-D30E0D45BC20Q41692604-1FC77D33-1E47-45FF-A1CC-3AC9C31A9CA6Q42017612-429AA172-22CD-4E65-AC31-830EC91B5483Q42609452-F9DAAFB2-0E7C-4ED6-AEF5-B5202D3D3280Q44693243-C5033C16-C765-4BC0-AB86-3DC46461C3FCQ44950046-E269F583-F809-44EA-A8D5-6F709D1F6466Q46543487-30F04A14-8017-4BD7-8361-93FE712AB03EQ46569726-F9A35FDE-165A-4A80-A726-F052DF80F4EFQ47221339-389FB900-1743-4A07-AC69-F5E5BB255F3BQ48125822-C624E6E8-0AF0-4087-850B-0B61813E0755Q58481759-EB0589BF-374D-4757-A2B3-D4A3C42F162EQ58481810-07EB6E91-7071-4350-841D-8199E757A34CQ58481864-7EDD992D-FF8D-411F-9134-76294B285EEAQ58481883-FB89886E-05A7-455F-B31D-4491B32C5838Q59089540-66F21D80-67CC-41F3-AB40-773B4DA08373
P2860
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Determinants of outcome after ...... blastic leukaemia XI protocol.
@en
Determinants of outcome after ...... blastic leukaemia XI protocol.
@nl
type
label
Determinants of outcome after ...... blastic leukaemia XI protocol.
@en
Determinants of outcome after ...... blastic leukaemia XI protocol.
@nl
prefLabel
Determinants of outcome after ...... blastic leukaemia XI protocol.
@en
Determinants of outcome after ...... blastic leukaemia XI protocol.
@nl
P2093
P2860
P1476
Determinants of outcome after ...... blastic leukaemia XI protocol.
@en
P2093
C Harrison
G Harrison
S Richards
UK Medical Research Council's Working Party on Childhood Leukaemia
P2860
P304
P356
10.1046/J.1365-2141.2001.02668.X
P407
P577
2001-04-01T00:00:00Z